261 related articles for article (PubMed ID: 20345767)
21. γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets.
Dorneburg C; Goß AV; Fischer M; Roels F; Barth TF; Berthold F; Kappler R; Oswald F; Siveke JT; Molenaar JJ; Debatin KM; Beltinger C
Oncotarget; 2016 Sep; 7(39):62799-62813. PubMed ID: 27588497
[TBL] [Abstract][Full Text] [Related]
22. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B
J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895
[TBL] [Abstract][Full Text] [Related]
23. Discovery of notch-sparing gamma-secretase inhibitors.
Augelli-Szafran CE; Wei HX; Lu D; Zhang J; Gu Y; Yang T; Osenkowski P; Ye W; Wolfe MS
Curr Alzheimer Res; 2010 May; 7(3):207-9. PubMed ID: 20088802
[TBL] [Abstract][Full Text] [Related]
24. gamma-secretase inhibitor induces adipogenesis of adipose-derived stem cells by regulation of Notch and PPAR-gamma.
Huang Y; Yang X; Wu Y; Jing W; Cai X; Tang W; Liu L; Liu Y; Grottkau BE; Lin Y
Cell Prolif; 2010 Apr; 43(2):147-56. PubMed ID: 20447060
[TBL] [Abstract][Full Text] [Related]
25. More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.
López-Nieva P; González-Sánchez L; Cobos-Fernández MÁ; Córdoba R; Santos J; Fernández-Piqueras J
Oncologist; 2021 Feb; 26(2):e298-e305. PubMed ID: 33191568
[TBL] [Abstract][Full Text] [Related]
26. Mutations in nicastrin protein differentially affect amyloid beta-peptide production and Notch protein processing.
Pamrén A; Wanngren J; Tjernberg LO; Winblad B; Bhat R; Näslund J; Karlström H
J Biol Chem; 2011 Sep; 286(36):31153-8. PubMed ID: 21768095
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of Notch signaling by a γ-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells.
Yu S; Zhang R; Liu F; Hu H; Yu S; Wang H
Oncol Rep; 2011 Nov; 26(5):1323-8. PubMed ID: 21805038
[TBL] [Abstract][Full Text] [Related]
28. The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer's Disease.
Nagase H; Nakayama K
Curr Drug Discov Technol; 2014; 11(4):243-58. PubMed ID: 25413946
[TBL] [Abstract][Full Text] [Related]
29. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.
Mori M; Miyamoto T; Yakushiji H; Ohno S; Miyake Y; Sakaguchi T; Hattori M; Hongo A; Nakaizumi A; Ueda M; Ohno E
Hum Cell; 2012 Mar; 25(1):9-15. PubMed ID: 22189483
[TBL] [Abstract][Full Text] [Related]
30. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester).
Morohashi Y; Kan T; Tominari Y; Fuwa H; Okamura Y; Watanabe N; Sato C; Natsugari H; Fukuyama T; Iwatsubo T; Tomita T
J Biol Chem; 2006 May; 281(21):14670-6. PubMed ID: 16569643
[TBL] [Abstract][Full Text] [Related]
31. Identification of High-affinity Small Molecules Targeting Gamma Secretase for the Treatment of Alzheimer's Disease.
Ali MA; Vuree S; Goud H; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1173-1187. PubMed ID: 31244427
[TBL] [Abstract][Full Text] [Related]
32. Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma.
Bu X; Li N; Tian X; Huang P
Neoplasma; 2011; 58(4):343-7. PubMed ID: 21520992
[TBL] [Abstract][Full Text] [Related]
33. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
[TBL] [Abstract][Full Text] [Related]
34. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
[TBL] [Abstract][Full Text] [Related]
35. Selective amyloid-beta lowering agents.
Wolfe MS
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S4. PubMed ID: 19090992
[TBL] [Abstract][Full Text] [Related]
36. Mercury is a direct and potent γ-secretase inhibitor affecting Notch processing and development in Drosophila.
Alattia JR; Kuraishi T; Dimitrov M; Chang I; Lemaitre B; Fraering PC
FASEB J; 2011 Jul; 25(7):2287-95. PubMed ID: 21415381
[TBL] [Abstract][Full Text] [Related]
37. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
[TBL] [Abstract][Full Text] [Related]
38. γ-Secretase Inhibition Induces Muscle Hypertrophy in a Notch-Independent Mechanism.
Rosa de Andrade I; Corrêa S; Fontenele M; de Oliveira Teixeira JD; Abdelhay E; Costa ML; Mermelstein C
Proteomics; 2018 Feb; 18(3-4):. PubMed ID: 29280566
[TBL] [Abstract][Full Text] [Related]
39. Exploring Alzheimer's disease in zebrafish.
Xia W
J Alzheimers Dis; 2010; 20(4):981-90. PubMed ID: 20182049
[TBL] [Abstract][Full Text] [Related]
40. Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.
Yoon SO; Zapata MC; Singh A; Jo WS; Spencer N; Choi YS
Apoptosis; 2014 Nov; 19(11):1616-26. PubMed ID: 25156146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
